Key Takeaways:
Bleichmar Fonti & Auld LLP is investigating Gildan Activewear Inc. for securities fraud after a research report triggered an 18.75% stock drop on June 16.
The law firm is probing whether Gildan misled investors about the true drivers and sustainability of its reported revenue, according to a statement from BFA. The investigation centers on allegations that the apparel manufacturer engaged in a channel stuffing scheme to artificially inflate sales by pushing excess inventory onto wholesalers and distributors.
Gildan's stock fell $11.62 to close at $50.35 on June 16, down from $61.97 the prior session, after Jehoshaphat Research published a report titled "Stuffing All of the Channel Some of the Time?" The short seller alleged Gildan "has been stuffing the channel to make revenues look like they're growing" and that the practice "has been cannibalizing future demand and inflating the overall growth trajectory of this business." Jehoshaphat's claims were based on interviews with former employees, customers and distributors, according to the report.
Gildan, which produces T-shirts, fleece, underwear and socks sold primarily in bulk to wholesalers, screen printers and retailers, had previously attributed strong sales results to "share gains in key growth categories" and "strong market response to products introduced" with key innovations. The investigation will examine whether those statements were materially false or misleading to investors who relied on them when making purchase decisions.
Gildan competes with Hanesbrands Inc. and Fruit of the Loom in the basic apparel market, where bulk sales to screen printers and promotional product distributors form a significant portion of revenue. Channel stuffing allegations are particularly concerning for this business model because distributor inventory levels directly affect future order patterns.
BFA has been recognized as a top plaintiff law firm by Chambers USA and The Legal 500, and its attorneys have been named among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon. Among its recent successes, the firm recovered more than $900 million in value from Tesla Inc.'s board of directors and $420 million from Teva Pharmaceutical Industries Ltd. BFA is offering affected investors the opportunity to join the investigation, with all representation on a contingency fee basis.
The probe puts Gildan's revenue quality under scrutiny and raises the risk that future quarters could show a demand pullback as channel inventory normalizes. Channel stuffing typically pulls forward sales that would otherwise occur in later periods, meaning Gildan's reported growth may have been inflated at the expense of future results. Investors who purchased shares before the June 16 decline may have legal options, with BFA offering representation on a contingency fee basis with no upfront costs. Gildan's next quarterly earnings report will be a key test for whether the allegations have merit and how much demand was pulled forward. The company has not yet commented on the investigation or the Jehoshaphat report.
This article is for informational purposes only and does not constitute investment advice.
